Lotti Principio Precauzione
Lotti Principio Precauzione
Lotti Principio Precauzione
S0300-483X(16)30190-1
http://dx.doi.org/doi:10.1016/j.tox.2016.08.015
TOX 51734
To appear in:
Toxicology
Please cite this article as: An Appeal For The Integrity Of Science And Public Policy,
Toxicology (2016), http://dx.doi.org/10.1016/j.tox.2016.08.015
This is a PDF file of an unedited manuscript that has been accepted for publication.
As a service to our customers we are providing this early version of the manuscript.
The manuscript will undergo copyediting, typesetting, and review of the resulting proof
before it is published in its final form. Please note that during the production process
errors may be discovered which could affect the content, and all legal disclaimers that
apply to the journal pertain.
ip
t
Ac
ce
pt
e
Unlike unbiased science, the spurious science of our concern starts off from
arbitrary default assumptions that inevitably yield biased and
uninterpretable results, unable to quantify or estimate putative human
hazards. Similar concerns apply to advocating premature experimental
accounts that are not sufficiently tested and controlled. Examples are found
in animal, in vitro and in silico tests of presumed risk factors for human
cancer and endocrine disturbances, and in many epidemiologic surveys and
environmental impact assessments.
We agree that precautionary policies and regulations may be called for in
the absence of firm scientific evidence that would permit an assumption of
certainty. However, such precautionary regulations and policies should not
be imposed as if grounded on objective science, but should result from
public debates on wider issues including economic trade-offs between
desirable uses and cautious restrictions on exposure. Rather than being truly
precautionary, what might be called pseudo-science is a subterfuge to gloss
over arbitrary policies and regulations while claiming to be supported by the
impartial objectivity of the scientific method. Indeed, on such shaky
grounds the lifestyles, choices, and behaviors of nations are directed,
substantial segments of national economies are regulated, and unfortunate
transgressors face criminal charges, massive fines and detention.
cr
We, scientists and signatories of this appeal assert our concern for the
erosion of scientific principles in the purported validation of experimental
evidence, which is manifest in arguments disguised as true science. Such
arguments are used to simulate and exaggerate hazards and risks that justify
official intervention policies in health, safety and environmental issues. This
erodes public confidence in science and government, leads to misallocation
of public resources, cause massive economic distortions, and strains court
adjudications.
us
* Corresponding author:
Dr. Gio Batta Gori
Bethesda, Maryland
Email: gorigb@msn.com
an
Editorial
Page 1 of 12
Beth-Hbner, Maren, MD
Secretary General MEDICHEM BG RCI
German Social Accident Insurance Institute
for Raw Materials and Chemical Industry
Heidelberg, Germany
Email: maren.beth-huebner@bgrci.de
ip
t
cr
us
Ac
ce
pt
e
an
Page 2 of 12
us
cr
an
Ac
ce
pt
e
ip
t
Dencker, Lennart, MD
Professor Emeritus,
Department of Pharmaceutical Biosciences
Uppsala University, Uppsala, Sweden
Email: lennart.dencker@farmbio.uu.se
Esdaile, David J.
Director of Science and Regulatory Affairs
CiToxLAB Hungary
Veszprem, Hungary
Page 3 of 12
Assistant Provost
Professor of Molecular Toxicology
Surgery and Cancer, Imperial College London
London, UK
Email: n.gooderham@imperial.ac.uk
cr
us
an
Ac
ce
pt
e
ip
t
Email: david.esdaile@hu.citoxlab.com
Page 4 of 12
Email: joachim.haselbach@tox-consult.de
Toxicology Department
Hastings, Kenneth L. DrPH, DABT, Fellow ATS
Hastings Toxicology Consulting LLC
Mount Airy, MD, USA
Email: kennethhastingus@gmail.com
ip
t
Email: mihaela.ilie@umf.ro
Heistracher, Peter, MD
Professor Emeritus
University of Vienna
Vienna, Austria
Email: peter.heistracher@univie.ac.at
cr
Department of Toxicology
Faculty of Pharmacy, Ankara University
us
Ankara, Turkey
Email: Mumtaz.Iscan@pharmacy.ankara.edu.tr
an
Email: bernhard.jene@basf.com
Ac
ce
pt
e
Ludwigshafen, Germany
Page 5 of 12
Limburgerhof, Germany
Kellert, Marco, Dr., ERT
Email: hans-dieter.jungblut@basf.com
Wacker Chemie AG
Professor
Burghausen, Germany
Email: marco.kellert@wacker.com
cr
Email: skacew@uottawa.ca
ip
t
Email: bkelman@veritox.com
us
an
Email: kamins11@msu.edu
Affiliate Professor
Ac
ce
pt
e
Professor Emeritus
Email: curtisklaassenphd@gmail.com
Email: kamrin@msu.edu
Email: jklauni@indiana.edu
fr Naturwissenschaftler
Goethe-Universitt Frankfurt
Dsseldorf, Germany
Email: klein@em.uni-frankfurt.de
Email: detlef.keller@henkel.com
Page 6 of 12
and Carcinogenesis
UK Government
Email : mek59100@gmail.com
Kuopio, Finland
University of Oxford, UK
Email: hannu.komulainen@thl.fi
Email: chris.leaver@plants.ox.ac.uk
Wyeth/Pfizer Research
Email: toxsci@sbcglobal.net
us
an
cr
ip
t
Email: eml17@psu.edu
Ac
ce
pt
e
Doerenkamp-Zbinden Chair
Faculty of Mathematics and Sciences
University of Konstanz
Konstanz, Germany
Email: marcel.leist@uni-konstanz.de
Email: jlamb@exponent.com
Department of Pharmacology
Email: paul.leonard@basf.com
Email: l.h.lash@wayne.edu
Email: a.lerchl@jacobs-university.de
Page 7 of 12
Email: stevencraiglewis@comcast.net
cr
us
Hemmingen/Hannover, Germany
Email: Werner.Lilienblum@t-online.de
an
Lotti, Marcello, MD
Emeritus Professor of Medicine
Ac
ce
pt
e
e-mail: marcello.lotti@unipd.it
Department of Cardiological,
Thoracic and Vascular Sciences
ip
t
Email: juergen-alfred.lux@basf.com
Page 8 of 12
us
an
Ac
ce
pt
e
cr
ip
t
Page 9 of 12
Email: ksolomon@uoguelph.ca
cr
us
Schlatter, Josef R.
Dr. sc nat ETH Retired
Zurich, Switzerland
Email: Josef.schlatter@bluewin.ch
Ac
ce
pt
e
an
ip
t
Page 10 of 12
cr
us
an
Ac
ce
pt
e
ip
t
*Corresponding author
Page 11 of 12
Page 12 of 12
Ac
ce
pt
e
us
an
cr
ip
t